Cargando…

Machine learning cardiac-MRI features predict mortality in newly diagnosed pulmonary arterial hypertension

AIMS: Pulmonary arterial hypertension (PAH) is a rare but serious disease associated with high mortality if left untreated. This study aims to assess the prognostic cardiac magnetic resonance (CMR) features in PAH using machine learning. METHODS AND RESULTS: Seven hundred and twenty-three consecutiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Alabed, Samer, Uthoff, Johanna, Zhou, Shuo, Garg, Pankaj, Dwivedi, Krit, Alandejani, Faisal, Gosling, Rebecca, Schobs, Lawrence, Brook, Martin, Shahin, Yousef, Capener, Dave, Johns, Christopher S, Wild, Jim M, Rothman, Alexander M K, van der Geest, Rob J, Condliffe, Robin, Kiely, David G, Lu, Haiping, Swift, Andrew J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708011/
https://www.ncbi.nlm.nih.gov/pubmed/36713008
http://dx.doi.org/10.1093/ehjdh/ztac022
_version_ 1784840827526184960
author Alabed, Samer
Uthoff, Johanna
Zhou, Shuo
Garg, Pankaj
Dwivedi, Krit
Alandejani, Faisal
Gosling, Rebecca
Schobs, Lawrence
Brook, Martin
Shahin, Yousef
Capener, Dave
Johns, Christopher S
Wild, Jim M
Rothman, Alexander M K
van der Geest, Rob J
Condliffe, Robin
Kiely, David G
Lu, Haiping
Swift, Andrew J
author_facet Alabed, Samer
Uthoff, Johanna
Zhou, Shuo
Garg, Pankaj
Dwivedi, Krit
Alandejani, Faisal
Gosling, Rebecca
Schobs, Lawrence
Brook, Martin
Shahin, Yousef
Capener, Dave
Johns, Christopher S
Wild, Jim M
Rothman, Alexander M K
van der Geest, Rob J
Condliffe, Robin
Kiely, David G
Lu, Haiping
Swift, Andrew J
author_sort Alabed, Samer
collection PubMed
description AIMS: Pulmonary arterial hypertension (PAH) is a rare but serious disease associated with high mortality if left untreated. This study aims to assess the prognostic cardiac magnetic resonance (CMR) features in PAH using machine learning. METHODS AND RESULTS: Seven hundred and twenty-three consecutive treatment-naive PAH patients were identified from the ASPIRE registry; 516 were included in the training, and 207 in the validation cohort. A multilinear principal component analysis (MPCA)-based machine learning approach was used to extract mortality and survival features throughout the cardiac cycle. The features were overlaid on the original imaging using thresholding and clustering of high- and low-risk of mortality prediction values. The 1-year mortality rate in the validation cohort was 10%. Univariable Cox regression analysis of the combined short-axis and four-chamber MPCA-based predictions was statistically significant (hazard ratios: 2.1, 95% CI: 1.3, 3.4, c-index = 0.70, P = 0.002). The MPCA features improved the 1-year mortality prediction of REVEAL from c-index = 0.71 to 0.76 (P ≤ 0.001). Abnormalities in the end-systolic interventricular septum and end-diastolic left ventricle indicated the highest risk of mortality. CONCLUSION: The MPCA-based machine learning is an explainable time-resolved approach that allows visualization of prognostic cardiac features throughout the cardiac cycle at the population level, making this approach transparent and clinically interpretable. In addition, the added prognostic value over the REVEAL risk score and CMR volumetric measurements allows for a more accurate prediction of 1-year mortality risk in PAH.
format Online
Article
Text
id pubmed-9708011
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-97080112023-01-27 Machine learning cardiac-MRI features predict mortality in newly diagnosed pulmonary arterial hypertension Alabed, Samer Uthoff, Johanna Zhou, Shuo Garg, Pankaj Dwivedi, Krit Alandejani, Faisal Gosling, Rebecca Schobs, Lawrence Brook, Martin Shahin, Yousef Capener, Dave Johns, Christopher S Wild, Jim M Rothman, Alexander M K van der Geest, Rob J Condliffe, Robin Kiely, David G Lu, Haiping Swift, Andrew J Eur Heart J Digit Health Original Article AIMS: Pulmonary arterial hypertension (PAH) is a rare but serious disease associated with high mortality if left untreated. This study aims to assess the prognostic cardiac magnetic resonance (CMR) features in PAH using machine learning. METHODS AND RESULTS: Seven hundred and twenty-three consecutive treatment-naive PAH patients were identified from the ASPIRE registry; 516 were included in the training, and 207 in the validation cohort. A multilinear principal component analysis (MPCA)-based machine learning approach was used to extract mortality and survival features throughout the cardiac cycle. The features were overlaid on the original imaging using thresholding and clustering of high- and low-risk of mortality prediction values. The 1-year mortality rate in the validation cohort was 10%. Univariable Cox regression analysis of the combined short-axis and four-chamber MPCA-based predictions was statistically significant (hazard ratios: 2.1, 95% CI: 1.3, 3.4, c-index = 0.70, P = 0.002). The MPCA features improved the 1-year mortality prediction of REVEAL from c-index = 0.71 to 0.76 (P ≤ 0.001). Abnormalities in the end-systolic interventricular septum and end-diastolic left ventricle indicated the highest risk of mortality. CONCLUSION: The MPCA-based machine learning is an explainable time-resolved approach that allows visualization of prognostic cardiac features throughout the cardiac cycle at the population level, making this approach transparent and clinically interpretable. In addition, the added prognostic value over the REVEAL risk score and CMR volumetric measurements allows for a more accurate prediction of 1-year mortality risk in PAH. Oxford University Press 2022-05-02 /pmc/articles/PMC9708011/ /pubmed/36713008 http://dx.doi.org/10.1093/ehjdh/ztac022 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Alabed, Samer
Uthoff, Johanna
Zhou, Shuo
Garg, Pankaj
Dwivedi, Krit
Alandejani, Faisal
Gosling, Rebecca
Schobs, Lawrence
Brook, Martin
Shahin, Yousef
Capener, Dave
Johns, Christopher S
Wild, Jim M
Rothman, Alexander M K
van der Geest, Rob J
Condliffe, Robin
Kiely, David G
Lu, Haiping
Swift, Andrew J
Machine learning cardiac-MRI features predict mortality in newly diagnosed pulmonary arterial hypertension
title Machine learning cardiac-MRI features predict mortality in newly diagnosed pulmonary arterial hypertension
title_full Machine learning cardiac-MRI features predict mortality in newly diagnosed pulmonary arterial hypertension
title_fullStr Machine learning cardiac-MRI features predict mortality in newly diagnosed pulmonary arterial hypertension
title_full_unstemmed Machine learning cardiac-MRI features predict mortality in newly diagnosed pulmonary arterial hypertension
title_short Machine learning cardiac-MRI features predict mortality in newly diagnosed pulmonary arterial hypertension
title_sort machine learning cardiac-mri features predict mortality in newly diagnosed pulmonary arterial hypertension
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708011/
https://www.ncbi.nlm.nih.gov/pubmed/36713008
http://dx.doi.org/10.1093/ehjdh/ztac022
work_keys_str_mv AT alabedsamer machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension
AT uthoffjohanna machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension
AT zhoushuo machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension
AT gargpankaj machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension
AT dwivedikrit machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension
AT alandejanifaisal machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension
AT goslingrebecca machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension
AT schobslawrence machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension
AT brookmartin machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension
AT shahinyousef machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension
AT capenerdave machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension
AT johnschristophers machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension
AT wildjimm machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension
AT rothmanalexandermk machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension
AT vandergeestrobj machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension
AT condlifferobin machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension
AT kielydavidg machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension
AT luhaiping machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension
AT swiftandrewj machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension